跳至主要内容
临床试验/NCT03102359
NCT03102359Unknown2 期

Cerebral Protection Effect of Selective Head Cooling and Dexmedetomidine in Patients Undergoing Liver Transplantation

Huazhong University of Science and Technology1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2017年4月5日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
100
试验地点
1
主要终点
Postoperative minimal hepatic encephalopathy (MHE)

研究概览

简要总结

The investigators investigated in the present study whether selective head cooling and dexmedetomidine has an effect on cerebral oxygenation during liver transplantation and has cerebral protective effect in patients undergoing liver transplantation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Scheduled for OLT, selected from the Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China.
  • Sign the informed consent

排除标准

  • The patients with a history of neurological or psychiatric disorders which impair cognitive processes, including previously established de-mentia, stroke, schizophrenia and depression were excluded from the study.
  • Patients diagnosed with hepatic encephalopathy or had a low Mini-Mental State Examination (MMSE) score (below 24) preoperatively.
  • With concurrent diseases such as renal insufficiency, diabetes mellitus were also excluded.
  • Patients were excluded if severe reperfusion syn-drome (mean arterial pressure below 60mmHg sustained over 15minutes) occurred perioperatively.

研究组 & 干预措施

Selective Head Cooling

Experimental

Participants received a cooling helmet filled with ice water mixture after an-esthesia induction until the end of the surgery.

干预措施: Cooling Helmet (Device)

Dexmedetomidine

Experimental

Giving dexmedetomidine1μg/kg i.v for 10 minutes, then use computerized infusion pump at 0.5μg/kg.h until the end of the surgery.

干预措施: Dexmedetomidine (Drug)

Selective Head Cooling and Dexmedetomidine

Experimental

Using selective head cooling combined with dexmedetomidine as described before

干预措施: Dexmedetomidine (Drug)

Selective Head Cooling and Dexmedetomidine

Experimental

Using selective head cooling combined with dexmedetomidine as described before

干预措施: Cooling Helmet (Device)

结局指标

主要结局

Postoperative minimal hepatic encephalopathy (MHE)

时间窗: 14 days after surgery

Using PSE-Syndrom-Test

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Huawei He

Postgraduate

Huazhong University of Science and Technology

研究点 (1)

Loading locations...

相似试验